The United States Embryonic Stem Cell Research ban affects the country has also affected overseas

Business News, September 15 According to the "Nature" website, the recent temporary ban on the research of embryonic stem cells in the United States has caused a great impact on the research of embryonic stem cells in the United States. Now, this ban is international. The influence is also gradually emerging.

Benoit Bruneau, a developmental biologist at the Gladstone Institute of Cardiovascular Disease (GICD) at the University of California, San Francisco, recently established a partnership with Roger Pedersen, an expert on human embryonic stem cells at the University of Cambridge, UK, to prepare a study on the development of cardiomyocytes. Group family genes carry out research. Who knows, on August 23th, the United States District Court Judge Royce Lamberth issued such a temporary ban, which caused the two co-authors who were just starting to suffer from the cooperation.

"If this temporary ban has been in effect, our cooperation has basically disappeared," Bruneau said in an e-mail to Pedersen.

"Because Bruneau is a world-class expert in this area of ​​research, (but such a ban) will affect our application for funds on the British side, the development of this research, and its application to clinical purposes." Pedersen added.

Pedersen’s concerns highlight the international impact of this temporary ban. Many postdoctoral fellows in the United States watched as the project was about to end, many international cooperation projects were affected, and international confidence was shaken. Although the U.S. government is applying for a new ruling on this ban, the protracted court debate and investigation review means that the future of embryonic stem cell research is still unknown at least for the next few months.

"Those overseas high-end talents who are engaged in embryonic stem cell research may later go to other countries," said Stewart Anderson, of Weill Cornell Medical College in New York. "Embroider stem cell research will definitely continue, but it may not be in the United States." ".